Platelets: Biochemistry and physiology;Blutplättchen: Biochemie und physiologie

Hamostaseologie

Volumn 28, Issue 5, 2008, Pages 289-298

  Kehrel, Beate E ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Platelet adhesion; Platelet aggregation; Platelet interaction with cells; Platelet procoagulant activity

Indexed keywords

THROMBIN;

BLOOD CLOT RETRACTION; HEMOSTASIS; HUMAN; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE; THROMBOCYTE RELEASE REACTION; THROMBOEMBOLISM; THROMBOGENESIS;

EID: 58149470402     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1617177     Document Type: Review

References (72)

1. Ahamed J, Versteeg HH, Kerver M et al. Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc Natl Acad Sci USA 2006; 103: 13932-13937.
2. Aszodi A, Pfeifer A, Ahmad M et al. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function. EMBO J 1999; 18: 37-48.
3. Baglia FA, Shrimpton CN, Emsley J et al. Factor XI interacts with the leucine-rich repeats of glycoprotein Ibalpha on the activated platelet. J Biol Chem 2004; 279: 49323-49329.
4. Bergmeier W, Piffath CL, Goerge T et al. The role of platelet adhesion receptor GPIbalpha far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis. Proc Natl Acad Sci USA 2006; 103: 16900-16905.
5. Bevilacqua M, Butcher E, Furie B et al. Selectins: a family of adhesion receptors. Cell 67; 1991: 233.
6. Bouchard BA, Catcher CS, Thrash BR et al. Effector cell protease receptor-1, a platelet activation-dependent membrane protein, regulates prothrombinase-catalyzed thrombin generation. J Biol Chem 1999; 272: 9244-9251
7. Bouchard BA, Tracy PB. Platelets, leukocytes, and coagulation. Curr Opin Hematol 2001; 8: 263-269.
8. Brass LF, Hoxie JA, Manning DR. Signaling through G proteins and G protein-coupled receptors during platelet activation. Thromb Haemost 1993; 70: 217-223.
9. Brass LF, Pizarro S, Ahuja M et al. Changes in the structure and function of the human thrombin receptor during receptor activation, internalization, and recycling. J Biol Chem 1994; 269: 2943-2952.
10. Brass LF. More pieces of the platelet activation puzzle slide into place. J Clin Invest 1999; 104: 1663-1665.
11. Clemetson JM, Polgar J, Magnenat E et al. The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors. J Biol Chem 1999; 274: 29019-29024.
12. Clemetson KJ. Platelet activation: signal transduction via membrane receptors. Thromb Haemost 1995; 74: 111-116.
13. Clemetson KJ, Clemetson JM. Platelet GPIb-V-IX complex. Structure, function, physiology, and pathology. Semin Thromb Hemost 1995; 21: 130-136.
14. Clemetson KJ, Clemetson JM. Platelet collagen receptors. Thromb Haemost 2001; 86: 189-197.
15. Coller BS. Platelets and thrombolytic therapy. N Engl J Med 1990; 322: 33-42.
16. Coller BS. Antiplatelet agents in the prevention and therapy of thrombosis. Ann Rev Med 1992; 43: 171-180.
17. Coller BS. GPIIb/IIIa antagonists: pathophysiologic and therapeutic insights from studies of c7E3 Fab. Thromb Haemost 1997; 78: 730-735.
18. Dale GL, Friese P, Batar P et al. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature 2002; 415: 175-179.
19. Dörmann D, Kardoeus J, Zimmermann RE et al. Flowcytometric analysis of agonist-induced annexin V, factor Va and factor Xa binding to human platelets. Platelets 1998; 9: 171-177.
20. Dormann D, Clemetson KJ, Kehrel BE. The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity. Blood 2000; 96: 2469-2478.
21. Fox JE. The platelet cytoskeleton. Thromb Haemost 1993; 70: 884-893.
22. Frenette PS, Denis CV, Weiss L et al. P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J Exp Med 2000; 191: 1413-1422.
23. Fumeron F, Betoulle D, Nicaud V et al. Serotonin transporter gene polymorphism and myocardial infarction: Etude Cas-Temoins de l'In-farctus du Myocarde (ECTIM). Circulation 2002; 105: 2943-2945.
24. Furie B, Furie BC, Flaumenhaft R. A journey with platelet P-selectin: the molecular basis of granule secretion, signalling and cell adhesion. Thromb Haemost 2001; 86: 214-221.
25. Gachet C. ADP receptors of platelets and their inhibition. Thromb Haemost 2001; 86: 222-232.
26. Gao J, Zoller KE, Ginsberg MH et al. Regulation of the pp72syk protein tyrosine kinase by platelet integrin alpha IIb beta 3. EMBO J 1997; 16: 6414-6425.
27. George JN, Shattil SJ. The clinical importance of acquired abnormalities of platelet function. N Engl J Med 1991; 324: 27-39.
28. Gewirtz AM, Poncz M. Megakaryocytopoiesis and platelet function. In: Hoffmann R, Benz EJJr, Shattil SJ et al. (Hrsg). Hematology, Basic Principles and Practice. New York: Churchill-Livingstone 1991, 1148-1157.
29. Gupta GP, Massagué J. Platelets and metastasis revisited: a novel fatty link. J Clin Invest 2004; 114: 1691-1693.
30. Hoffman M, Monroe DM, Roberts HR. Platelet-dependent action of high-dose factor VIIa. Blood 2002; 100: 364-365.
31. Holme PA, Orvim U, Hamers MJ et al. Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis. Arterioscler Thromb Vasc Biol 1997; 17: 646-653.
32. Jurk K, Kehrel BE. The role of platelets in haemostasis, thrombosis, immune defense and inflammation Dtsch Med Wochenschr 2008; 133: 1130-1135.
33. Jurk K, Kehrel B. Thrombozytensekretion. In: Hämostaseologie. Madiener K, Pötzsch B, Gawaz M et al. (Hrsg). Heidelberg: Springer 2008.
34. Jurk K, Clemetson KJ, de Groot PG et al. Thrombospondin-1 mediates platelet adhesion at high shear via glycoprotein Ib (GPIb): an alternative/ backup mechanism to von Willebrand factor. FASEB J 2003; 17: 1490-1492.
35. Kaushansky K, Drachman JG. The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production. Oncogene 2002; 21: 3359-3367.
36. Kehrel B, Balleisen L, Kokott R et al. Deficiency of intact thrombospondin and membrane glycoprotein Ia in platelets with defective collagen-induced aggregation and spontaneous loss of disorder. Blood 1988; 71: 1074-1078.
37. Kehrel B. Platelet-collagen interactions. Semin Thromb Hemost 1995; 21: 123-129.
38. Kehrel B, Flicker E, Wigbels B et al. Thrombospondin measured in whole blood - an indicator of platelet activation. Blood Coagul Fibrinol 1996: 7: 202-205.
39. Kehrel BE, Wierwille S, Clemetson KJ et al. Glycoprotein VI is a major collagen receptor for platelet activation: it recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb/IIIa, and von Willebrand factor do not. Blood 1998; 91: 491-499.
40. Lahav J, Jurk K, Hess O et al. Sustained integrin ligation involves extracellular free sulfhydryls and enzymatically catalyzed disulfide exchange. Blood 2002; 100: 2472-2478.
41. Langer HF, Gawaz M. Platelet-vessel wall interactions in atherosclerotic disease. Thromb Haemost 2008; 99: 480-486.
42. Lindemann S, Tolley ND, Dixon DA et al. Activated platelets mediate inflammatory signaling by regulated interleukin lbeta synthesis. J Cell Biol 2001; 154: 485-490.
43. Lüscher EF, Weber S. The formation of the haemostatic plug - a special case of platelet aggregation. An experiment and a survey of the literature. Thromb Haemost 1993; 70: 234-237.
44. Marcus AJ, Broekman MJ, Drosopoulos JH et al. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 1997; 99: 1351-1360.
45. May AE, Seizer P, Gawaz M. Platelets: inflammatory firebugs of vascular walls. Arterioscler Thromb Vasc Biol 2008; 28: s5-s10.
46. Monroe DM, Hoffman M, Oliver JA et al. Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol 1997; 99: 542-547.
47. Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 2002; 22: 1381-1389.
48. th Meeting of the GTH, 17. 2. 2001 Düsseldorf. Ann Hematol 2001; 80: A48.
49. Morgenstern E. Morphologie der Thrombozyten. In: Müller-Berghaus G, Pötzsch B (Hrsg). Hämostaseologie. Berlin, Heidelberg: Springer 1999, 1-14.
50. Nesheim ME, Furmaniak-Kazmierczak E, Henin C et al. On the existence of platelet receptors for factor V(a) and factor VIII(a). Thromb Haemost 1993; 70: 80-86.
51. Newman PJ. Switched at birth: a new family for PECAM-1. J Clin Invest 1999; 103: 5-9.
52. Newton-Nash DK, Newman PJ. A new role for platelet-endothelial cell adhesion molecule-1 (CD31): inhibition of TCR-mediated signal transduction. J Immunol 1999; 163: 682-688.
53. Nieuwland R, Berckmans RJ, Rotteveel-Eijkman RC et al. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation 1997; 96: 3534-3541.
54. Oliver JA, Monroe DM, Roberts HR et al. Thrombin activates factor XI on activated platelets in the absence of factor XII. Arterioscler Thromb Vasc Biol 1999; 19: 170-177.
55. Phillips DR, Law D, Scarborough RM. Glycoprotein IIb-IIIa in platelet aggregation: an emerging target for the prevention of acute coronary thrombotic occlusions. Arch Pathol Lab Med 1998; 122: 811-812.
56. Polgar J, Clemetson JM, Kehrel BE et al. Platelet activation and signal transduction by convulxin, a C-type lectin from Crotalus durissus terrificus (tropical rattlesnake) venom via the p62/GPVI collagen receptor. J Biol Chem 1997; 272: 13576-13583.
57. Rao AK. Congenital disorders of platelet function. Hematol Oncol Clin North Am 1990; 4: 65-86.
58. Rao AK. Congenital disorders of platelet function: disorders of signal transduction and secretion. Am J Med Sci 1998; 316: 69-76.
59. Reinhardt C, von Brühl ML, Manukyan D et al. Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. J Clin Invest 2008; 118: 1110-1122.
60. Reininger AJ, Heijnen HF, Schumann H et al. Mechanism of platelet adhesion to von Willebrand factor and microparticle formation under high shear stress. Blood 2006; 107: 3537-3545.
61. Rinder CS, Student LA, Bonan JL et al. Aspirin does not inhibit adenosine diphosphate-induced platelet alpha- granule release. Blood 1993; 82: 505-512.
62. Romo GM, Dong JF, Schade AJ et al. The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P- selectin. J Exp Med 1999; 190: 803-814
63. Ruggeri ZM. Mechanisms of shear-induced platelet adhesion and aggregation. Thromb Haemost 1993; 70: 119-123.
64. Savage B, Shattil SJ, Ruggeri ZM. Modulation of platelet function through adhesion receptors. A dual role for glycoprotein IIb-IIIa (integrin alpha IIb beta 3) mediated by fibrinogen and glycoprotein Ib-von Willebrand factor. J Biol Chem 1992; 267: 11300-11306.
65. Scandura JM, Walsh PN. Factor X bound to the surface of activated human platelets is preferentially activated by platelet-bound factor IXa. Biochemistry 1996; 35: 8903-8913.
66. Schulz C, Penz S, Hoffmann C et al. Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo. Basic Res Cardiol 2008; 103: 356-367.
67. Schwarz UR, Walter U, Eigenthaler M. Taming platelets with cyclic nucleotides. Biochem Pharmacol 2001; 62: 1153-1161.
68. Shattil SJ, Ginsberg MH, Brugge JS. Adhesive signaling in platelets. Curr Opin Cell Biol 1994; 6: 695-704.
69. Sims PJ, Wiedmer T, Esmon CT et al. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity J Biol Chem 1989; 264: 17049-17057.
70. Von Hundelshausen P, Weber C. Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res 2007; 100: 27-40.
71. Walter U, Eigenthaler M, Geiger J et al. Role of cyclic nucleotide-dependent protein kinases and their common substrate VASP in the regulation of human platelets. Adv Exp Med Biol 1993; 344: 237-249.
72. Wiedmer T, Shattil SJ, Cunningham M et al. Role of calcium and calpain in complement-induced vesiculation of the platelet plasma membrane and in the exposure of the platelet factor Va receptor. Biochemistry 1990; 29: 623-632.